348 related articles for article (PubMed ID: 29989863)
1. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
Koopai M; Mortazavi H; Khatami A; Khodashenas Z
Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
[TBL] [Abstract][Full Text] [Related]
2. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
3. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
4. Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris.
Avgerinou G; Papafragkaki DK; Nasiopoulou A; Markantoni V; Arapaki A; Servitzoglou M; Katsambas A; Stavropoulos PG
J Eur Acad Dermatol Venereol; 2013 Apr; 27(4):430-5. PubMed ID: 22221266
[TBL] [Abstract][Full Text] [Related]
5. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
Barnadas MA; Rubiales MV; Gich I; Gelpí C
Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029
[TBL] [Abstract][Full Text] [Related]
7. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
Russo I; Saponeri A; Michelotto A; Alaibac M
In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
[TBL] [Abstract][Full Text] [Related]
8. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
10. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
[TBL] [Abstract][Full Text] [Related]
11. High anti–desmoglein 3 antibody ELISA index and negative indirect immunofluorescence result in a patient with pemphigus vulgaris in remission: evaluation of the antibody profile by newly developed methods.
Nakahara T; Takagi A; Yamagami J; Kamiya K; Aoyama Y; Iwatsuki K; Ikeda S
JAMA Dermatol; 2014 Dec; 150(12):1327-30. PubMed ID: 25075929
[TBL] [Abstract][Full Text] [Related]
12. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
[TBL] [Abstract][Full Text] [Related]
13. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
[TBL] [Abstract][Full Text] [Related]
14. Using desmoglein 1 and 3 enzyme-linked immunosorbent assay as an adjunct diagnostic tool for pemphigus.
Huang CH; Chen CC; Wang CJ; Chang YT; Liu HN
J Chin Med Assoc; 2007 Feb; 70(2):65-70. PubMed ID: 17339147
[TBL] [Abstract][Full Text] [Related]
15. Antidesmoglein 1 and 3 antibodies in healthy subjects of a population in the Peruvian high amazon.
Ramos W; Díaz J; Gutierrez EL; Lazarte JS; Bohnett MC; Ronceros G; Ortega-Loayza AG
Int J Dermatol; 2018 Mar; 57(3):344-348. PubMed ID: 29130480
[TBL] [Abstract][Full Text] [Related]
16. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
18. Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays.
Mortazavi H; Saeidi V; Balighi K; Esmaeili N; Teimourpour A; Daneshpazhooh M; Hamzelou S; Saffarian Z; Taghizadeh Fazli J
Iran J Allergy Asthma Immunol; 2023 Jun; 22(3):312-318. PubMed ID: 37524667
[TBL] [Abstract][Full Text] [Related]
19. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody Levels and Clinical Disease Severity in Patients with Pemphigus: Comparison of Aggregated Anti-desmoglein ELISA Values and Indirect Immunofluorescence Titres.
Weiss D; Ristl R; Griss J; Bangert C; Foedinger D; Stingl G; Brunner PM
Acta Derm Venereol; 2015 May; 95(5):559-64. PubMed ID: 25423997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]